Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-30 00:36 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Technology & AI, Economy & Finance, China, Financial Markets, Drugs, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
BEIJING — U.S. pharmaceutical giant Eli Lilly has reached a $2.75 billion deal to bring drugs developed using artificial intelligence by Hong Kong-based Insilico Medicine to the global market.
--------------------------------------------------------------------